Showing 20 of 10402 recruiting trials
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
👨⚕️ Aimee Talleur, MD, St. Jude Children's Research Hospital📍 1 site📅 Started May 2025View details ↗
Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
👨⚕️ Jeremy Rubinstein, MD, PhD, Children's Hospital Medical Center, Cincinnati📍 1 site📅 Started May 2025View details ↗
RecruitingNCT06703736 ↗
Functional and Morphological Characterization of Multiple Osteochondromas Disorder
Teclistamab in Previously Treated AL Amyloidosis
An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis
🏥 The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started May 2025View details ↗
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
Comparison of the Effectiveness of Oral and Intratympanic Corticosteroid Treatments in Patients Diagnosed With Sudden Sensorineural Hearing Loss
👨⚕️ Rasim Yılmazer, Dr. Lutfi Kirdar Kartal Training and Research Hospital📍 1 site📅 Started May 2025View details ↗
Treatment Outcomes and Patient Satisfaction of Oral Lichen Planus Treatment
👨⚕️ Sally A ElHaddad, Assist. Prof, Dar AlUloom University, SA📍 1 site📅 Started May 2025View details ↗
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
👨⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 36 sites📅 Started May 2025View details ↗
GMP Powdered Substitutes in PKU and TYR
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLC
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
Safety and Tolerability of Low Motoneuron Stimulation Via Transcranial Magnetic Stimulation in Spinal Muscular Atrophy
👨⚕️ Olena V Pisotska, MD, PhD, P.V. Voloshyn Institute of Neurology, Psychiatry and Narcology of the National Academy of Medical Sciences of Ukraine📍 1 site📅 Started May 2025View details ↗
RecruitingNCT07202494 ↗
Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
👨⚕️ François CREMIEUX, Assistance Publique - Hôpitaux de Marseille📍 1 site📅 Started May 2025View details ↗
Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →